Name: Ultherapy PRIME
Brand: noufillaser
SKU: HIFU-PRIME
Availability: InStock
Rating: 5 (1 reviews)

Home > Medical Aesthetic > HIFU

Description

MEET ULTHERAPY PRIME

Ultherapy PRIME® is the evolution of the Gold Standard in nonsurgical skin lifting and tightening that you have been waiting for:

See the difference of an ADVANCED system with VIVID real-time visualization technology, built on Ultherapy's PROVEN RESULTS as the category leader, with over 3 million nonsurgical skin-lifting treatments and one of the largest installation bases worldwide.

ULTHERAPY PRIME® IS ADVANCED

See a smoother operational experience for you and your patients through Ultherapy PRIME®'s:

20% faster platform & Elevated system performance & Ergonomic advances & Sophisticated design

SOPHISTICATED-LOOKING PLATFORM to meet the needs of modern aesthetics practices
TILTABLE SCREEN for optimal viewing angles
INTEGRATED WORK SURFACE to keep treatment equipment in place
ERGONOMICALLY ANGLED CART PLATFORM for easy interaction with the device
QUIET SYSTEM SOUNDS for a better treatment experience

LARGE 19-INCH, HIGH-RESOLUTION, capacitive touchscreen
FASTER REFRESH RATE of the ultrasound imaging due to new powerful system components
INSTANT RESPONSE time to commands
10X FASTER PROCESSING PERFORMANCE through a new dual-core processor
NEARLY TWICE AS FAST BOOT-UP TIME from power on to use readiness
IMPROVED STABILITY AND MEMORY MANAGEMENT paired with a new operating system and modern drivers to enable future software innovations

* Average reported increase in system speed over legacy Ultherapy® device based on a survey of providers.

ULTHERAPY PRIME® IS VIVID

See an elevated visualization experience with Ultherapy PRIME®'s:

35% LARGER screen

2X LARGER ultrasound field

REDUCED VISUAL NOISE FOR STABLE, CLEAR IMAGING up to 8mm depth

EASY-TO-USE GRAPHICAL USER INTERFACE for intuitive workflows

Human avatar with modern, patient-resembling appeal

ULTHERAPY PRIME® IS PROVEN

Uplift your practice with the evolution of the category leader and Gold Standard in non-invasive skin lifting, built on a strong legacy of:

95% patient satisfaction at year one

The strongest* clinical body of evidence with over 50 clinical studies and more than 120 peer-reviewed papers published

Over 3 million treatments performed in more than 80 countries worldwide

One of the largest installed bases worldwide

*Strongest among non-invasive ultrasound devices

HANDPIECE

Ergonomically designed for precise control and reduction of grip fatigue during treatment, the handpiece works with six different Ultherapy ultrasound transducers.

TRANSDUCERS

Ultherapy PRIME®'s patented DeepSEE® transducers provide simultaneous visualization and treatment. These multi-patient-use transducers treat at three separate depths—superficial dermis at 1.5mm, deep dermis at 3mm, and SMAS/platysma at 4.5mm. Tissues may be visualized with collimated ultrasound to 8mm.

Send your message to us

* Email

* Country

please select your country

Afghanistan
Aland Islands
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antigua and Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia and Herzegovina
Botswana
Bouvet Island
Brazil
British Indian Ocean Territory
British Virgin Islands
Brunei Darussalam
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Caribbean Netherlands
Cayman Islands
Central African Republic
Chad
Chile
China
Christmas Island
Cocos Islands
Colombia
Comoros
Congo
Cook Islands
Costa Rica
Cote D'ivoire
Cuba
Curaçao
Cyprus
Czech Republic
Democratic People's Republic of Korea
Democratic Republic of the Congo
Denmark
Djibouti
Dominica
East Timor
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Falkland Islands
Faroe Islands
Fiji
Finland
France
French Guiana
French Polynesia
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Greece
Greenland
Grenada
Guadeloupe
Guam
Guatemala
Guernsey
Guinea
Guinea-Bissau
Guyana
Haiti
Heard Island and Mcdonald Islands
Honduras
Hong Kong, China
Hungary
Iceland
India
Indonesia
Iran
Iraq
Ireland
Isle of Man
Israel
Italy
Jamaica
Japan
Jordan
Kazakhstan
Kenya
Kiribati
Korea
Kosovo
Kuwait
Kyrgyzstan
Laos
Latvia
Lebanon
Lesotho
Liberia
Liechtenstein
Lithuania
Luxembourg
Macau, China
Macedonia
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique
Mauritania
Mauritius
Mayotte
Mexico
Micronesia
Moldova
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
Netherlands Antilles
New Caledonia
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Palestine
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn Islands
Poland
Portugal
Puerto Rico
Qatar
Reunion
Romania
Russia
Rwanda
Saint Barthélemy
Saint Helena
Saint Kitts and Nevis
Saint Lucia
Saint Martin
Saint Pierre and Miquelon
Saint Vincent and the Grenadines
San Marino
Sao Tome and Principe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Sint Maarten
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South Georgia and The South Sandwich Islands
Spain
Sri Lanka
State of Libya
Sudan
Suriname
Svalbard and Jan Mayen
Swaziland
Sweden
Switzerland
Syrian Arab Republic
TaiWan, China
Tajikistan
Tanzania
Thailand
The Republic of Croatia
Togo
Tokelau
Tonga
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Turks and Caicos Islands
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States
United States Minor Outlying Islands
Uruguay
US Virgin Islands
Uzbekistan
Vanuatu
Vatican City State
Venezuela
Vietnam
Wallis and Futuna Islands
Western Sahara
Western Samoa
Yemen
Zambia
Zimbabwe

* Message

* Verification code